Interdigitating Reticulum Cell Sarcoma Positive immunohistochemistry for HLA-DR and two other activation antigens,...

Area of Science:

• Hematology
• Oncology
• Immunopathology

Background:

• Interdigitating reticulum cell (IDRC) sarcoma is a rare neoplastic proliferation of lymph nodes.
• Accurate diagnosis relies on comprehensive immunophenotypic analysis.

Purpose of the Study:

• To report a rare case of IDRC sarcoma in a 46-year-old male patient.
• To characterize the immunophenotype of neoplastic cells in IDRC sarcoma.
• To discuss the significance of co-expression of activation antigens.

Main Methods:

• Extensive immunophenotypic analysis was performed on paraffin and frozen lymph node sections.
• Utilized a panel of antibodies targeting protein S-100 and various cell surface antigens (CD1, HLA-DR, CD4, CD25/IL2R, CD30/Ki-1).

Main Results:

• Neoplastic cells showed positivity for protein S-100 and antigens CD1, HLA-DR, CD4, CD25 (IL2R), and CD30 (Ki-1).
• Observed simultaneous positivity for the activation antigens CD30, HLA-DR, and IL2R.
• This co-expression pattern is typically seen in Hodgkin's disease.

Conclusions:

• The immunophenotype of this IDRC sarcoma case provides valuable diagnostic information.
• The co-expression of CD30, HLA-DR, and IL2R highlights potential shared pathways with Hodgkin's disease.
• Further research may elucidate the pathobiology of IDRC sarcoma.